Could S-100b Be a Marker of the Neurologic Involvement in HIV-Affected Patients?

Orandle M.S. MacLean A.G. Sasseville V.G. Alvarez X. Lackner A.A. , 2002. Enhanced expression of proinflammatory cytokines in the central nervous system by simian immunodeficiency virus and the development of encephalitis. J. Virol. 76:5797.

Vecchiet J. Dalessandro M. Falasca K. Di Iorio A. Travasi F. Zingariello P. Schiavone C. Ensoli F. Pizzigallo E. Paganelli R. , 2003. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J. Acquir. Immune Deficienc. Syndr. 32:464.

Mrak R.E. Griffinbc W.S. , 2001. The role of activated astrocytes and of the neurotrophic cytokine S 100b in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 22:915.

Infante J.R. Martinez A. Ochoa J. Canadillas F. Torres-Avisbal M. Vallejo J.A. Gonzales F.M. Pacheco C. Latre J.M. , 2003. Cerebrospinal fluid S-100 protein levels in neurological pathologies. J. Physiol. Biochem. 59:255.

Raabe A. Kopetsch O. Woszczyk A. Lang J. Gerlach R. Zimmermann M. Seifert V. , 2003. Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor. Neurol. Neurosci. 21:159.

Pemberton L.A. Brew B.J. , 2001. Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J. Clin. Virol. 22:249.

Corasiniti M.T. Rotiroti D. Nappi G. Bagetta G. , 2003. Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS. Toxicol. Lett. 139:199.

Fagnart O.C. Sindic C.J. Laterrec C. 1988. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin. Chem. 34:1387.

Green A.J. Giovannoni G. Hall-Craggs M.A. Thompson E.J. Miller R.F. , 1999. Cerebrospinal fluid S-100b concentrations in patients with HIV infection. AIDS 13:139.

Vecchiet J. Dalessandro M. Travasi F. Falasca K. Di Iorio A. Schiavone C. Zingariello P. Di Ilio E. Pizzigallo E. , 2003. Interleukin-4 and Interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. Int. J. Immunopathol. Pharmacol. 16:33.